CAS 902135-91-5: N-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide hydrochloride
Fórmula:C16H17Cl2N5O2.HCl
InChI:InChI=1S/C16H17Cl2N5O2.ClH/c17-10-2-1-3-11(18)13(10)15(24)22-12-8-20-23-14(12)16(25)21-9-4-6-19-7-5-9;/h1-3,8-9,19H,4-7H2,(H,20,23)(H,21,25)(H,22,24);1H
- Sinónimos:
- At 7519
- N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide Hcl
- AT-7519(HCl)
- AT7519 HCl
![discount label](https://static.cymitquimica.com/public/img/discount.png)
N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide Hcl
CAS:902135-91-5
Fórmula:
C16H18Cl3N5O2
Pureza:
99%
Forma y color:
Solid
Peso molecular:
418.7054
Ref: IN-DA00GRUQ
10mg | 153,00 € | ||
25mg | 190,00 € | ||
50mg | 282,00 € | ||
100mg | 638,00 € |
Entrega estimada en Estados Unidos, el Lunes 3 de Marzo de 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Ref: 7W-GW4564
1mg | 181,00 € | ||
5mg | 281,00 € | ||
10mg | 406,00 € |
Entrega estimada en Estados Unidos, el Lunes 10 de Marzo de 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
AT7519 Hydrochloride
CAS:902135-91-5
AT7519 Hydrochloride (AT7519 HCl) is a multi-CDK inhibitor for CDK1, 2, 4, 6 and 9.
Fórmula:
C16H18Cl3N5O2
Pureza:
99.66% - 99.9%
Forma y color:
Solid
Peso molecular:
418.71
Ref: TM-T1778
5mg | 57,00 € | ||
10mg | 87,00 € | ||
25mg | 111,00 € | ||
50mg | 166,00 € | ||
1mL*10mM (DMSO) | 59,00 € |
Entrega estimada en Estados Unidos, el Lunes 10 de Marzo de 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
4-(2,6-Dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide HCl
CAS:902135-91-5
4-(2,6-Dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide HCl (PD1693) is a small molecule that has been shown to selectively inhibit the …
Fórmula:
C16H17Cl2N5O2·HCl
Pureza:
Min. 95%
Forma y color:
Powder
Peso molecular:
418.7 g/mol
Ref: 3D-FD32785
25mg | 170,00 € | ||
50mg | 240,00 € |
Entrega estimada en Estados Unidos, el Viernes 14 de Marzo de 2025